Companies:
10,785
total market cap:
$133.783 T
Sign In
๐บ๐ธ
EN
English
$ USD
โฌ
EUR
๐ช๐บ
โน
INR
๐ฎ๐ณ
ยฃ
GBP
๐ฌ๐ง
$
CAD
๐จ๐ฆ
$
AUD
๐ฆ๐บ
$
NZD
๐ณ๐ฟ
$
HKD
๐ญ๐ฐ
$
SGD
๐ธ๐ฌ
Global ranking
Ranking by countries
America
๐บ๐ธ United States
๐จ๐ฆ Canada
๐ฒ๐ฝ Mexico
๐ง๐ท Brazil
๐จ๐ฑ Chile
Europe
๐ช๐บ European Union
๐ฉ๐ช Germany
๐ฌ๐ง United Kingdom
๐ซ๐ท France
๐ช๐ธ Spain
๐ณ๐ฑ Netherlands
๐ธ๐ช Sweden
๐ฎ๐น Italy
๐จ๐ญ Switzerland
๐ต๐ฑ Poland
๐ซ๐ฎ Finland
Asia
๐จ๐ณ China
๐ฏ๐ต Japan
๐ฐ๐ท South Korea
๐ญ๐ฐ Hong Kong
๐ธ๐ฌ Singapore
๐ฎ๐ฉ Indonesia
๐ฎ๐ณ India
๐ฒ๐พ Malaysia
๐น๐ผ Taiwan
๐น๐ญ Thailand
๐ป๐ณ Vietnam
Others
๐ฆ๐บ Australia
๐ณ๐ฟ New Zealand
๐ฎ๐ฑ Israel
๐ธ๐ฆ Saudi Arabia
๐น๐ท Turkey
๐ท๐บ Russia
๐ฟ๐ฆ South Africa
>> All Countries
Ranking by categories
๐ All assets by Market Cap
๐ Automakers
โ๏ธ Airlines
๐ซ Airports
โ๏ธ Aircraft manufacturers
๐ฆ Banks
๐จ Hotels
๐ Pharmaceuticals
๐ E-Commerce
โ๏ธ Healthcare
๐ฆ Courier services
๐ฐ Media/Press
๐ท Alcoholic beverages
๐ฅค Beverages
๐ Clothing
โ๏ธ Mining
๐ Railways
๐ฆ Insurance
๐ Real estate
โ Ports
๐ผ Professional services
๐ด Food
๐ Restaurant chains
โ๐ป Software
๐ Semiconductors
๐ฌ Tobacco
๐ณ Financial services
๐ข Oil&Gas
๐ Electricity
๐งช Chemicals
๐ฐ Investment
๐ก Telecommunication
๐๏ธ Retail
๐ฅ๏ธ Internet
๐ Construction
๐ฎ Video Game
๐ป Tech
๐ฆพ AI
>> All Categories
ETFs
๐ All ETFs
๐๏ธ Bond ETFs
๏ผ Dividend ETFs
โฟ Bitcoin ETFs
โข Ethereum ETFs
๐ช Crypto Currency ETFs
๐ฅ Gold ETFs & ETCs
๐ฅ Silver ETFs & ETCs
๐ข๏ธ Oil ETFs & ETCs
๐ฝ Commodities ETFs & ETNs
๐ Emerging Markets ETFs
๐ Small-Cap ETFs
๐ Low volatility ETFs
๐ Inverse/Bear ETFs
โฌ๏ธ Leveraged ETFs
๐ Global/World ETFs
๐บ๐ธ USA ETFs
๐บ๐ธ S&P 500 ETFs
๐บ๐ธ Dow Jones ETFs
๐ช๐บ Europe ETFs
๐จ๐ณ China ETFs
๐ฏ๐ต Japan ETFs
๐ฎ๐ณ India ETFs
๐ฌ๐ง UK ETFs
๐ฉ๐ช Germany ETFs
๐ซ๐ท France ETFs
โ๏ธ Mining ETFs
โ๏ธ Gold Mining ETFs
โ๏ธ Silver Mining ETFs
๐งฌ Biotech ETFs
๐ฉโ๐ป Tech ETFs
๐ Real Estate ETFs
โ๏ธ Healthcare ETFs
โก Energy ETFs
๐ Renewable Energy ETFs
๐ก๏ธ Insurance ETFs
๐ฐ Water ETFs
๐ด Food & Beverage ETFs
๐ฑ Socially Responsible ETFs
๐ฃ๏ธ Infrastructure ETFs
๐ก Innovation ETFs
๐ Semiconductors ETFs
๐ Aerospace & Defense ETFs
๐ Cybersecurity ETFs
๐ฆพ Artificial Intelligence ETFs
Watchlist
Account
Photronics
PLAB
#4390
Rank
$2.38 B
Marketcap
๐บ๐ธ
United States
Country
$40.41
Share price
9.28%
Change (1 day)
94.65%
Change (1 year)
๐ Semiconductors
๐ฉโ๐ป Tech
Categories
Market cap
Revenue
Earnings
Price history
P/E ratio
P/S ratio
More
Price history
P/E ratio
P/S ratio
P/B ratio
Operating margin
EPS
Stock Splits
Shares outstanding
Fails to deliver
Cost to borrow
Total assets
Total liabilities
Total debt
Cash on Hand
Net Assets
Annual Reports (10-K)
Photronics
Quarterly Reports (10-Q)
Financial Year FY2025 Q1
Photronics - 10-Q quarterly report FY2025 Q1
Text size:
Small
Medium
Large
false
10-31
2025
Q1
0000810136
P91D
P103D
P6M
P3D
P30D
P1M
P24M
P7D
P14D
P14D
P21D
P2M
P1Y
P1Y
2019
0000810136
2024-11-01
2025-02-02
0000810136
2025-03-06
0000810136
2024-10-31
0000810136
2025-02-02
0000810136
2023-11-01
2024-01-28
0000810136
us-gaap:AdditionalPaidInCapitalMember
2024-10-31
0000810136
2023-10-31
0000810136
us-gaap:NoncontrollingInterestMember
2024-10-31
0000810136
us-gaap:RetainedEarningsMember
2023-10-31
0000810136
us-gaap:NoncontrollingInterestMember
2023-10-31
0000810136
us-gaap:CommonStockMember
2023-10-31
0000810136
us-gaap:RetainedEarningsMember
2024-10-31
0000810136
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-10-31
0000810136
us-gaap:CommonStockMember
2024-10-31
0000810136
us-gaap:AdditionalPaidInCapitalMember
2023-10-31
0000810136
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-10-31
0000810136
us-gaap:RetainedEarningsMember
2024-11-01
2025-02-02
0000810136
us-gaap:AdditionalPaidInCapitalMember
2023-11-01
2024-01-28
0000810136
us-gaap:RetainedEarningsMember
2023-11-01
2024-01-28
0000810136
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2023-11-01
2024-01-28
0000810136
us-gaap:NoncontrollingInterestMember
2024-11-01
2025-02-02
0000810136
us-gaap:CommonStockMember
2023-11-01
2024-01-28
0000810136
us-gaap:AdditionalPaidInCapitalMember
2024-11-01
2025-02-02
0000810136
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-11-01
2025-02-02
0000810136
us-gaap:NoncontrollingInterestMember
2023-11-01
2024-01-28
0000810136
us-gaap:CommonStockMember
2024-11-01
2025-02-02
0000810136
us-gaap:RetainedEarningsMember
2025-02-02
0000810136
us-gaap:NoncontrollingInterestMember
2024-01-28
0000810136
us-gaap:CommonStockMember
2024-01-28
0000810136
us-gaap:AdditionalPaidInCapitalMember
2024-01-28
0000810136
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2024-01-28
0000810136
us-gaap:CommonStockMember
2025-02-02
0000810136
us-gaap:AccumulatedOtherComprehensiveIncomeMember
2025-02-02
0000810136
us-gaap:NoncontrollingInterestMember
2025-02-02
0000810136
us-gaap:RetainedEarningsMember
2024-01-28
0000810136
us-gaap:AdditionalPaidInCapitalMember
2025-02-02
0000810136
2024-01-28
0000810136
plab:MitchellGTysonMember
2024-11-01
2025-02-02
0000810136
plab:ChristopherJProglerMember
2024-11-01
2025-02-02
0000810136
plab:MitchellGTysonMember
2025-02-02
0000810136
plab:ChristopherJProglerMember
2025-02-02
0000810136
us-gaap:EmployeeStockOptionMember
2024-11-01
2025-02-02
0000810136
us-gaap:RestrictedStockMember
2024-11-01
2025-02-02
0000810136
country:KR
2024-11-01
2025-02-02
0000810136
country:CN
2024-11-01
2025-02-02
0000810136
country:US
2024-11-01
2025-02-02
0000810136
country:TW
2024-11-01
2025-02-02
0000810136
srt:EuropeMember
2024-11-01
2025-02-02
0000810136
us-gaap:CashMember
2025-02-02
0000810136
us-gaap:CashMember
2024-10-31
0000810136
us-gaap:FairValueInputsLevel2Member
us-gaap:BankTimeDepositsMember
2024-10-31
0000810136
us-gaap:BankTimeDepositsMember
us-gaap:FairValueInputsLevel2Member
2025-02-02
0000810136
us-gaap:MoneyMarketFundsMember
us-gaap:FairValueInputsLevel1Member
2025-02-02
0000810136
us-gaap:FairValueInputsLevel1Member
us-gaap:MoneyMarketFundsMember
2024-10-31
0000810136
us-gaap:BuildingAndBuildingImprovementsMember
2024-10-31
0000810136
us-gaap:MachineryAndEquipmentMember
2024-10-31
0000810136
us-gaap:LeaseholdImprovementsMember
2025-02-02
0000810136
us-gaap:LandMember
2025-02-02
0000810136
us-gaap:MachineryAndEquipmentMember
2025-02-02
0000810136
us-gaap:LeaseholdImprovementsMember
2024-10-31
0000810136
us-gaap:BuildingAndBuildingImprovementsMember
2025-02-02
0000810136
us-gaap:FurnitureAndFixturesMember
2024-10-31
0000810136
us-gaap:ConstructionInProgressMember
2024-10-31
0000810136
us-gaap:ConstructionInProgressMember
2025-02-02
0000810136
us-gaap:LandMember
2024-10-31
0000810136
us-gaap:FurnitureAndFixturesMember
2025-02-02
0000810136
srt:MinimumMember
plab:PhotronicsAndDNPMember
2024-11-01
2025-02-02
0000810136
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2024-11-01
2025-02-02
0000810136
us-gaap:VariableInterestEntityNotPrimaryBeneficiaryMember
2018-01-01
2018-01-31
0000810136
plab:PhotronicsAndDNPMember
2024-11-01
2025-02-02
0000810136
plab:PhotronicsAndDNPMember
2023-11-01
2024-01-28
0000810136
plab:PDMCXMember
2024-10-31
0000810136
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2025-02-02
0000810136
plab:PDMCXMember
2025-02-02
0000810136
us-gaap:VariableInterestEntityPrimaryBeneficiaryMember
2024-10-31
0000810136
plab:FinanceLeaseMember
2025-02-02
0000810136
plab:FinanceLeaseMember
2024-10-31
0000810136
plab:FinanceLeaseMember
2023-11-01
2024-10-31
0000810136
plab:FinanceLeaseMember
2024-11-01
2025-02-02
0000810136
plab:Seven2MillionFinanceLeaseMember
2025-02-02
0000810136
plab:Three55MillionFinanceLeaseMember
2025-02-02
0000810136
plab:Three55MillionFinanceLeaseMember
2020-12-31
0000810136
plab:Seven2MillionFinanceLeaseMember
2021-02-28
0000810136
plab:Seven2MillionFinanceLeaseMember
plab:MonthlyMember
2021-02-01
2021-02-28
0000810136
plab:Three55MillionFinanceLeaseMember
plab:FirstThreeMonthsMember
2021-01-01
2021-01-31
0000810136
plab:Three55MillionFinanceLeaseMember
plab:FollowingNineMonthsMember
2021-01-01
2021-01-31
0000810136
plab:FollowedByThirtySixMonthsMember
plab:Three55MillionFinanceLeaseMember
2021-01-01
2021-01-31
0000810136
plab:Three55MillionFinanceLeaseMember
2021-01-31
0000810136
plab:WorkingCapitalLoanMember
2018-11-30
0000810136
plab:WorkingCapitalLoanMember
2024-08-31
0000810136
plab:WorkingCapitalLoanMember
2022-12-01
2022-12-31
0000810136
plab:WorkingCapitalLoanMember
2024-11-01
2025-02-02
0000810136
plab:WorkingCapitalLoanMember
2025-02-02
0000810136
us-gaap:OtherCurrentAssetsMember
2024-10-31
0000810136
us-gaap:OtherCurrentAssetsMember
2025-02-02
0000810136
us-gaap:OtherLiabilitiesMember
2025-02-02
0000810136
us-gaap:OtherLiabilitiesMember
2024-10-31
0000810136
us-gaap:AccruedLiabilitiesMember
2025-02-02
0000810136
us-gaap:AccruedLiabilitiesMember
2024-10-31
0000810136
srt:MinimumMember
2024-11-01
2025-02-02
0000810136
srt:MaximumMember
2024-11-01
2025-02-02
0000810136
plab:IntegratedCircuitsMember
srt:MinimumMember
2024-11-01
2025-02-02
0000810136
plab:IntegratedCircuitsMember
srt:MaximumMember
2024-11-01
2025-02-02
0000810136
plab:FlatPanelDisplaysMember
srt:MinimumMember
2024-11-01
2025-02-02
0000810136
plab:FlatPanelDisplaysMember
srt:MaximumMember
2024-11-01
2025-02-02
0000810136
us-gaap:TransferredAtPointInTimeMember
2023-11-01
2024-01-28
0000810136
plab:MainstreamIntegratedCircuitsMember
2024-11-01
2025-02-02
0000810136
plab:IntegratedCircuitsMember
2024-11-01
2025-02-02
0000810136
country:TW
2023-11-01
2024-01-28
0000810136
country:KR
2023-11-01
2024-01-28
0000810136
plab:FlatPanelDisplaysMember
2024-11-01
2025-02-02
0000810136
country:CN
2023-11-01
2024-01-28
0000810136
plab:HighEndFlatPanelDisplaysMember
2024-11-01
2025-02-02
0000810136
plab:MainstreamFlatPanelDisplaysMember
2024-11-01
2025-02-02
0000810136
plab:MainstreamIntegratedCircuitsMember
2023-11-01
2024-01-28
0000810136
country:US
2023-11-01
2024-01-28
0000810136
plab:OtherMember
2024-11-01
2025-02-02
0000810136
plab:HighEndFlatPanelDisplaysMember
2023-11-01
2024-01-28
0000810136
plab:HighEndIntegratedCircuitsMember
2023-11-01
2024-01-28
0000810136
plab:HighEndIntegratedCircuitsMember
2024-11-01
2025-02-02
0000810136
us-gaap:TransferredOverTimeMember
2024-11-01
2025-02-02
0000810136
plab:FlatPanelDisplaysMember
2023-11-01
2024-01-28
0000810136
srt:EuropeMember
2023-11-01
2024-01-28
0000810136
us-gaap:TransferredOverTimeMember
2023-11-01
2024-01-28
0000810136
us-gaap:TransferredAtPointInTimeMember
2024-11-01
2025-02-02
0000810136
plab:OtherMember
2023-11-01
2024-01-28
0000810136
plab:IntegratedCircuitsMember
2023-11-01
2024-01-28
0000810136
plab:MainstreamFlatPanelDisplaysMember
2023-11-01
2024-01-28
0000810136
2023-03-15
0000810136
2023-03-16
0000810136
2023-03-16
2023-03-16
0000810136
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2024-11-01
2025-02-02
0000810136
us-gaap:ResearchAndDevelopmentExpenseMember
2023-11-01
2024-01-28
0000810136
us-gaap:SellingGeneralAndAdministrativeExpensesMember
2023-11-01
2024-01-28
0000810136
us-gaap:RestrictedStockMember
2023-11-01
2024-01-28
0000810136
us-gaap:ResearchAndDevelopmentExpenseMember
2024-11-01
2025-02-02
0000810136
us-gaap:CostOfSalesMember
2024-11-01
2025-02-02
0000810136
us-gaap:EmployeeStockMember
2023-11-01
2024-01-28
0000810136
us-gaap:EmployeeStockMember
2024-11-01
2025-02-02
0000810136
us-gaap:CostOfSalesMember
2023-11-01
2024-01-28
0000810136
us-gaap:EmployeeStockOptionMember
srt:MinimumMember
2024-11-01
2025-02-02
0000810136
us-gaap:EmployeeStockOptionMember
srt:MaximumMember
2024-11-01
2025-02-02
0000810136
srt:MinimumMember
us-gaap:RestrictedStockMember
2024-11-01
2025-02-02
0000810136
us-gaap:RestrictedStockMember
srt:MaximumMember
2024-11-01
2025-02-02
0000810136
us-gaap:RestrictedStockMember
2024-01-28
0000810136
us-gaap:RestrictedStockMember
2025-02-02
0000810136
us-gaap:EmployeeStockOptionMember
2023-11-01
2024-01-28
0000810136
us-gaap:EmployeeStockOptionMember
2024-01-28
0000810136
us-gaap:EmployeeStockOptionMember
2025-02-02
0000810136
us-gaap:StockCompensationPlanMember
2024-11-01
2025-02-02
0000810136
us-gaap:StockCompensationPlanMember
2023-11-01
2024-01-28
0000810136
plab:AccumulatedOtherComprehensiveIncomeOtherMember
2023-10-31
0000810136
plab:AccumulatedOtherComprehensiveIncomeOtherMember
2024-10-31
0000810136
us-gaap:AccumulatedTranslationAdjustmentMember
2023-10-31
0000810136
us-gaap:AccumulatedTranslationAdjustmentMember
2024-10-31
0000810136
us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
2023-11-01
2024-01-28
0000810136
us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember
2023-11-01
2024-01-28
0000810136
plab:AccumulatedOtherComprehensiveIncomeIncludingPortionAttributableToNoncontrollingInterestOtherMember
2024-11-01
2025-02-02
0000810136
plab:AccumulatedOtherComprehensiveIncomeIncludingPortionAttributableToNoncontrollingInterestOtherMember
2023-11-01
2024-01-28
0000810136
us-gaap:AccumulatedForeignCurrencyAdjustmentIncludingPortionAttributableToNoncontrollingInterestMember
2024-11-01
2025-02-02
0000810136
us-gaap:AociIncludingPortionAttributableToNoncontrollingInterestMember
2024-11-01
2025-02-02
0000810136
us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember
2024-11-01
2025-02-02
0000810136
us-gaap:AccumulatedForeignCurrencyAdjustmentAttributableToNoncontrollingInterestMember
2023-11-01
2024-01-28
0000810136
us-gaap:AociAttributableToNoncontrollingInterestMember
2024-11-01
2025-02-02
0000810136
us-gaap:AociAttributableToNoncontrollingInterestMember
2023-11-01
2024-01-28
0000810136
plab:AccumulatedOtherComprehensiveIncomeAttributableToNoncontrollingInterestOtherMember
2024-11-01
2025-02-02
0000810136
plab:AccumulatedOtherComprehensiveIncomeAttributableToNoncontrollingInterestOtherMember
2023-11-01
2024-01-28
0000810136
us-gaap:AccumulatedTranslationAdjustmentMember
2024-01-28
0000810136
plab:AccumulatedOtherComprehensiveIncomeOtherMember
2025-02-02
0000810136
us-gaap:AccumulatedTranslationAdjustmentMember
2025-02-02
0000810136
plab:AccumulatedOtherComprehensiveIncomeOtherMember
2024-01-28
0000810136
plab:September2020AnnouncedProgramMember
2020-09-30
0000810136
plab:ShareRepurchaseProgramsMember
2024-08-31
0000810136
plab:ShareRepurchaseProgramsMember
2020-09-16
2022-10-31
0000810136
plab:ShareRepurchaseProgramsMember
2024-11-01
2025-02-02
0000810136
plab:ShareRepurchaseProgramsMember
2024-07-31
0000810136
plab:September2020AnnouncedProgramMember
2025-02-02
xbrli:shares
iso4217:USD
iso4217:USD
xbrli:shares
plab:Facility
xbrli:pure
iso4217:CNY
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
10-Q
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended
February 2, 2025
OR
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from ___ to ___
Commission file number
0-15451
PHOTRONICS, INC.
(Exact name of registrant as specified in its charter)
Connecticut
06-0854886
(State or other jurisdiction of incorporation or organization)
(IRS Employer Identification No.)
15 Secor Road
,
Brookfield
,
Connecticut
06804
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code
(
203
)
775-9000
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
COMMON STOCK
PLAB
NASDAQ
Global Select Market
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes
☒
No
☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes
☒
No
☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):
Large Accelerated Filer
Accelerated Filer
Non-Accelerated Filer
Smaller
Reporting Company
Emerging
Growth company
☒
☐
☐
☐
☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes
☐
No
☒
The registrant had
63,561,709
shares of common stock outstanding as of March 6, 2025.
PHOTRONICS, INC.
QUARTERLY REPORT ON FORM 10-Q
February 2, 2025
TABLE OF CONTENTS
Glossary of Terms and Acronyms
3
Forward-Looking Statements
4
PART I.
FINANCIAL INFORMATION
Item 1.
Financial Statements (unaudited)
5
Condensed Consolidated Balance Sheets
5
Condensed Consolidated Statements of Income
6
Condensed Consolidated Statements of Comprehensive Income
7
Condensed Consolidated Statements of Equity
8
Condensed Consolidated Statements of Cash Flows
9
Notes to Condensed Consolidated Financial Statements
10
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
23
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
29
Item 4.
Controls and Procedures
30
PART II.
OTHER INFORMATION
Item 1.
Legal Proceedings
31
Item 1A.
Risk Factors
31
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
31
Item 3.
Defaults Upon Senior Securities
31
Item 4.
Mine Safety Disclosures
31
Item 5.
Other Information
32
Item 6.
Exhibits
33
2
Table of Contents
Glossary of Terms and Acronyms
Definitions of certain terms and acronyms that may appear in this report are provided below.
AMOLED
Active-matrix organic light-emitting diode. A technology used in mobile devices.
ASC
Accounting Standards Codification
ASP
Average Selling Price
ASU
Accounting Standards Update
CNY
Chinese Yuan
DNP
Dai Nippon Printing Co., Ltd.
Exchange Act
The Securities Exchange Act of 1934 (as amended)
Form 10-K
Annual Report on Form 10-K
Form 10-Q
Quarterly Report on Form 10-Q
FPD
Flat Panel Display
FY
Fiscal Year
Generation
In reference to flat panel displays, refers to the size range of the underlying substrate to which a photomask is applied. Higher generation (or “G”) numbers represent larger substrates
High-end (photomasks)
For IC, photomasks that
service IC nodes at
28nm or smaller; for FPD, AMOLED, G10.5+, and LTPS photomasks
IC
Integrated circuit
LTPS
Low-Temperature Poly Silicon, a polycrystalline silicon synthesized at relatively low temperatures; polycrystalline silicon in thin-film transistors (TFTs) are used in liquid-crystal display (LCD) flat panels and to drive organic light-emitting diode (OLED) displays
Mainstream (photomasks)
For IC, photomasks that service IC nodes greater than 28nm; for FPD, G8 and smaller photomasks
PDMCX
Xiamen American Japan Photronics Mask Co., Ltd., a joint venture of Photronics and DNP
ROU (assets)
Right-of-use asset
SEC
Securities and Exchange Commission
Securities Act
The Securities Act of 1933 (as amended)
U.S. GAAP
Accounting principles generally accepted in the United States of America
VIE
Variable Interest Entity
Wafer
A wafer, or silicon wafer, is a thin slice of semiconductor material that, in the fabrication of microelectronics, serves as the substrate for microelectronic devices built in and upon the wafer
3
Table of Contents
Forward-Looking Statements
This Form 10-Q contains forward-looking statements, as defined by the SEC. The Private Securities Litigation Reform Act of 1995 provides a “safe harbor” for forward-looking statements made by us, or on our behalf. Forward-looking statements are statements other than statements of historical fact, including, without limitation, those statements that include such words as “anticipates”, “believes”, “estimates”, “expects”, “intends”, “may”, “plans”, “predicts”, and similar expressions, and, without limitation, may address our future plans, objectives, goals, strategies, events, or performance, as well as underlying assumptions and other statements that are other than statements of historical facts. On occasion, in other documents filed with the SEC, press releases, conferences, or by other means, we may discuss, publish, disseminate, or otherwise make available, forward-looking statements, including statements contained within Part I, Item 2 – “Management’s Discussion & Analysis of Financial Condition and Results of Operations” of this Form 10-Q.
Forward-looking statements involve risks and uncertainties, which could cause actual results or outcomes to differ materially from those expressed. Our expectations, beliefs, and projections are expressed in good faith and are believed by us to have a reasonable basis, including, without limitation, management’s examination of historical operating trends, information contained in our records, and information we’ve obtained from other parties. However, we can offer no assurance that our expectations, beliefs, or projections will be realized, accomplished, or achieved.
Forward-looking statements within this Form 10-Q speak only as of the date of its filing, and we undertake no obligation to update any such statements to reflect changes in events or circumstances that may subsequently occur. Users of this Form 10-Q are cautioned that various factors may cause actual results to differ materially from those contained in any forward-looking statements found within this Form 10-Q and that they should not place undue reliance on any forward-looking statement. In addition, all forward-looking statements, whether written or oral and whether made by us or on our behalf, are expressly qualified by the risk factors provided in Part I, Item 1A “Risk Factors” on Form 10-K for the year ended October 31, 2024, filed with the SEC on December 19, 2024, as well as any additional risk factors we may provide in Part II, Item 1A in this Quarterly Report on Form 10-Q.
4
Table of Contents
PART I.
FINANCIAL INFORMATION
Item 1.
FINANCIALSTATEMENTS
PHOTRONICS, INC.
Condensed
ConsolidatedBalanceSheets
(in thousands, except per share amounts)
(unaudited)
February 2,
2025
October 31,
2024
ASSETS
Current assets:
Cash and cash equivalents
$
642,200
$
598,485
Short-term investments
-
42,184
Accounts receivable, net of allowance of $
1,104
in 2025 and $
1,126
in 2024
188,438
200,830
Inventories
57,583
56,527
Other current assets
32,613
33,036
Total current assets
920,834
931,062
Property, plant and equipment, net
749,809
745,257
Deferred income taxes
19,338
23,059
Other assets
14,690
12,681
Total assets
$
1,704,671
$
1,712,059
LIABILITIES AND EQUITY
Current liabilities:
Current portion of long-term debt
$
2,631
$
17,972
Accounts payable
85,936
78,717
Accrued liabilities
74,076
87,122
Total current liabilities
162,643
183,811
Long-term debt
21
25
Other liabilities
47,798
47,464
Total liabilities
210,462
231,300
Commitments and contingencies (Note 12)
Equity:
Preferred stock, $
0.01
par value,
2,000
shares authorized,
none
issued and outstanding
-
-
Common stock, $
0.01
par value,
150,000
shares authorized,
62,303
shares issued and outstanding as of February 2, 2025, and
61,949
shares issued and outstanding as of October 31, 2024
623
619
Additional paid-in capital
515,742
514,757
Retained earnings
731,709
691,807
Accumulated other comprehensive
loss
(
120,325
)
(
86,319
)
Total Photronics, Inc. shareholders’ equity
1,127,749
1,120,864
Noncontrolling interests
366,460
359,895
Total equity
1,494,209
1,480,759
Total liabilities and equity
$
1,704,671
$
1,712,059
See accompanying notes to condensed consolidated financial statements.
5
Table of Contents
PHOTRONICS, INC.
CondensedConsolidated
Statements of Income
(in thousands, except per share amounts)
(unaudited)
Three Months Ended
February 2,
2025
January 28,
2024
Revenue
$
212,138
$
216,334
Cost of goods sold
136,603
137,079
Gross profit
75,535
79,255
Operating expenses:
Selling, general, and administrative
19,101
18,321
Research and development
4,257
3,445
Total operating expenses
23,358
21,766
Operating income
52,177
57,489
Other income (expense):
Foreign currency transactions impact, net
18,443
(
8,908
)
Interest income and other income, net
6,585
5,251
Interest expense
(
47
)
(
90
)
Income before income tax provision
77,158
53,742
Income tax provision
18,901
14,660
Net income
58,257
39,082
Net income attributable to noncontrolling interests
15,406
12,902
Net income attributable to Photronics, Inc. shareholders
$
42,851
$
26,180
Earnings per share attributable to Photronics, Inc. shareholders:
Basic
$
0.69
$
0.43
Diluted
$
0.68
$
0.42
Weighted-average number of common shares outstanding:
Basic
62,093
61,455
Diluted
62,661
62,283
See accompanying notes to condensed consolidated financial statements.
6
Table of Contents
PHOTRONICS, INC.
Condensed Consolidated
Statements ofComprehensive Income
(in thousands)
(unaudited)
Three Months Ended
February 2,
2025
January 28,
2024
Net income
$
58,257
$
39,082
Other comprehensive (loss) income, net of tax:
Foreign currency translation adjustments
(
42,917
)
31,493
Other
70
(
27
)
Net other comprehensive (loss) income
(
42,847
)
31,466
Comprehensive income
15,410
70,548
Less: comprehensive income attributable to noncontrolling interests
6,566
23,497
Comprehensive income attributable to Photronics, Inc. shareholders
$
8,844
$
47,051
See accompanying notes to condensed consolidated financial statements.
7
Table of Contents
PHOTRONICS, INC.
Condensed Consolidated
Statements of Equity
(in thousands)
(unaudited)
Three Months Ended February 2, 2025
Photronics, Inc. Shareholders
Additional
Paid-in
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Non-
controlling
Interests
Total
Equity
Common Stock
Shares
Amount
Balance as of October 31, 2024
61,949
$
619
$
514,757
$
691,807
$
(
86,319
)
$
359,895
$
1,480,759
Net income
-
-
-
42,851
-
15,406
58,257
Other comprehensive income (loss)
-
-
-
-
(
34,006
)
(
8,841
)
(
42,847
)
Shares issued under equity plans
549
6
(
727
)
-
-
-
(
721
)
Share-based compensation expense
-
-
3,334
-
-
-
3,334
Purchase and retirement of common stock through repurchase program
(
195
)
(
2
)
(
1,622
)
(
2,949
)
-
-
(
4,573
)
Balance as of
February 2, 2025
62,303
$
623
$
515,742
$
731,709
$
(
120,325
)
$
366,460
$
1,494,209
Three
Months Ended
January 28, 2024
Photronics, Inc. Shareholders
Additional
Paid-in
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Income (Loss)
Non-
controlling
Interests
Total
Equity
Common Stock
Shares
Amount
Balance at October 31, 2023
61,310
$
613
$
502,010
$
561,119
$
(
88,734
)
$
300,601
$
1,275,609
Net income
-
-
-
26,180
-
12,902
39,082
Other comprehensive income
-
-
-
-
20,871
10,595
31,466
Shares issued under equity plans
436
4
(
1,680
)
-
-
-
(
1,676
)
Share-based compensation expense
-
-
2,573
-
-
-
2,573
Balance at
January 28, 2024
61,746
$
617
$
502,903
$
587,299
$
(
67,863
)
$
324,098
$
1,347,054
See accompanying notes to condensed consolidated financial statements.
8
Table of Contents
PHOTRONICS, INC.
CondensedConsolidated Statements of
Cash Flows
(in thousands)
(unaudited)
Three Months Ended
February 2,
2025
January 28,
2024
Cash flows from operating activities:
Net income
$
58,257
$
39,082
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
20,792
20,702
Share-based compensation
3,334
2,573
Changes in assets and liabilities:
Accounts receivable
7,869
(
2,906
)
Inventories
(
2,533
)
409
Other current assets
(
522
)
(
2,844
)
Accounts payable, accrued liabilities, and other
(
8,731
)
(
15,508
)
Net cash provided by operating activities
78,466
41,508
Cash flows from investing activities:
Purchases of property, plant and equipment
(
35,200
)
(
43,314
)
Purchases of short-term investments
-
(
2,436
)
Proceeds from maturities of short-term investments
41,482
2,500
Government incentives
620
1,091
Other
(
57
)
(
56
)
Net cash provided by (used in) investing activities
6,845
(
42,215
)
Cash flows from financing activities:
Repayments of debt
(
15,343
)
(
1,194
)
Common stock repurchases
(
4,573
)
-
Proceeds from share-based arrangements
1,433
936
Net settlements of restricted stock awards
(
1,995
)
(
2,613
)
Net cash used in financing activities
(
20,478
)
(
2,871
)
Effects of exchange rate changes on cash, cash equivalents, and restricted cash
(
21,202
)
13,026
Net increase in cash, cash equivalents, and restricted cash
43,631
9,448
Cash, cash equivalents, and restricted cash at beginning of period
601,243
501,867
Cash, cash equivalents, and restricted cash at end of period
644,874
511,315
Less: Ending restricted cash
2,674
2,797
Cash and cash equivalents at end of period
$
642,200
$
508,518
Supplemental disclosure of non-cash information:
Accruals for property, plant and equipment purchased not yet paid
$
10,911
$
1,628
See accompanying notes to condensed consolidated financial statements
.
9
Table of Contents
PHOTRONICS, INC.
Notes to Condensed Consolidated Financial Statements
(unaudited)
(in thousands, except share amounts and per share data)
NOTE
1 – NATURE OF BUSINESS AND BASIS OF PRESENTATION
Description of Business
Photronics, Inc. (“Photronics”, “the Company”, “we”, “our”, or “us”) is one of the world’s leading manufacturers of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of ICs and FPDs and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during the fabrication of ICs, a variety of FPDs and, to a lesser extent, other types of electrical and optical components. The Company operates
eleven
manufacturing facilities, which are located in Taiwan (
3
), South Korea (
1
), China (
2
), the United States (
3
), and Europe (
2
).
Basis of Presentation
The preparation of financial statements in conformity with U.S. GAAP requires the Company to make estimates and assumptions that affect amounts reported in them. The Company’s estimates are based on historical experience and on various assumptions that the Company believes to be reasonable under the facts and circumstances at the time they are made. Subsequent actual results may differ from such estimates. The Company reviews these estimates periodically and reflects any effects of revisions in the period in which they are determined.
Principles of Consolidation
The accompanying unaudited condensed consolidated financial statements (“the financial statements”) have been prepared in accordance with U.S. GAAP for interim financial information, and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for annual financial statements. In the opinion of management, adjustments, all of which are of a normal recurring nature, considered necessary for a fair presentation have been included. The financial statements include the accounts of Photronics, its wholly owned subsidiaries, and the majority-owned subsidiaries, which it controls. All intercompany balances and transactions have been eliminated in consolidation.
These financial statements should be read in conjunction with the consolidated financial statements and accompanying notes included in the
Company’s
Form 10-K for the fiscal year ended October 31, 2024, where the Company discusses and provides additional information about the
Company’s
accounting policies and the methods and assumptions used in
the Company’s estimates.
The
Company’s
business is typically impacted during the first quarter of
the Company’s
fiscal year by the North American, European, and Asian holiday periods, as some customers reduce their development and buying activities during this period. Operating results for the interim periods are not necessarily indicative of the results that may be expected for the fiscal year ending October 31, 2025.
Recent Accounting Pronouncements
In
November 2024, the Financial Accounting Standards Board (the “FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses (“ASU 2024-03”) and in January 2025, the FASB issued ASU No. 2025-01, Income Statement - Reporting Comprehensive Income - Expense Disaggregation Disclosures (Subtopic 220-40): Clarifying the Effective Date, which clarified the effective date of ASU 2024-03. ASU 2024-03 will require the Company to disclose the amounts of purchases of inventory, employee compensation, depreciation and intangible asset amortization, as applicable, as well as qualitatively describe remaining amounts included in those captions. The guidance in this Update will be effective for Photronics in its fiscal year 2028 Form 10-K, with early application of the amendments allowed. The Company is currently evaluating the effect the adoption of this ASU may have on the Company’s disclosures.
10
Table of Contents
In
December 2023, the FASB issued ASU 2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures”, to enhance the transparency and decision usefulness of income tax disclosures. The amendments in this Update relate to the rate reconciliation and income taxes paid disclosures to improve the transparency of income tax disclosures by requiring (1) consistent categories and greater disaggregation of information in the rate reconciliation and (2) income taxes paid disaggregated by jurisdiction. The amendments allow investors to better assess, in their capital allocation decisions, how an entity’s worldwide operations and related tax risks and tax planning and operational opportunities affect its income tax rate and prospects for future cash flows. The guidance in this Update will be effective for Photronics in its fiscal year 2026 Form 10-K, with early application of the amendments allowed.
The Company is currently evaluating the effect the adoption of this ASU may have on the Company’s disclosures.
In November 2023, the FASB issued ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures”, which improves reportable segment disclosure requirements, primarily through enhanced disclosures about significant segment expenses. The guidance in this Update is effective for Photronics in its fiscal year 2025 Form 10-K, with early adoption permitted. The Company is currently evaluating the effect the adoption of this ASU may have on the Company’s disclosures.
NOTE 2
– ACCOUNTS RECEIVABLE, NET
The components of
Accounts Receivable,
net
at the balance sheet dates are presented below.
February 2,
October 31,
2025
2024
Accounts Receivable
$
149,711
$
172,741
Unbilled Receivable
39,831
29,215
Allowance for Credit Losses
(
1,104
)
(
1,126
)
$
188,438
$
200,830
11
Table of Contents
NOTE 3
–
CASH, CASH EQUIVALENTS AND INVESTMENTS
The Company invests excess cash primarily in bank time deposits and money market funds. The Company’s classification of investments is as follows:
-
Maturing within three months or less from the date of purchase
Cash and cash equivalents
-
Maturing, as of the date of purchase, more than three months, but with remaining maturities of less than one year, from the balance sheet date
Short-term investments
-
Maturing one year or more from the balance sheet date
Long-term marketable investments
The accounting framework for determining fair value includes a hierarchy for ranking the quality and reliability of the information used to measure fair value, which enables the reader of the financial statements to assess the inputs used to develop those measurements. The fair value hierarchy consists of three tiers as follows:
Level 1- These are investments where values are based on unadjusted quoted prices for identical assets in an active market the Company has the ability to access.
Level 2- These are investments where values are based on quoted market prices that are not active or model derived valuations in which all significant inputs are observable in active markets.
Level 3- These are investments where values are derived from techniques in which one or more significant inputs are unobservable.
The following are cash, cash equivalents and investments measured at fair value:
February 2, 2025
October 31, 2024
Cash and cash equivalents
Short-term investments
Total Fair Value
Cash and cash equivalents
Short-term investments
Total Fair Value
Cash
$
207,590
$
-
$
207,590
$
414,074
$
-
$
414,074
Level 1
Money market funds
91,740
-
91,740
36,322
-
36,322
Level 2
Time deposits
342,870
-
342,870
148,089
42,184
(1)
190,273
$
642,200
$
-
$
642,200
$
598,485
$
42,184
$
640,669
Restricted Cash
(2)
2,674
2,758
Cash, cash equivalents, and restricted cash
$
644,874
$
601,243
(1)
Matured during the first quarter of 2025.
(2)
Restricted cash is included in other current assets and primarily relates to land lease agreements and customs requirements.
Based
upon the Company’s intent and ability to hold its time deposits to maturity (which maturities range up to
twelve months
at purchase), such securities have been classified as held-to-maturity and are carried at amortized cost, which approximates market value.
In the event of a sale of these securities, the Company would determine the cost of the investment sold at the specific individual security level and would include any gain or loss in
Interest income and other income, net
, where the Company also reports periodic interest earned and the amortization (accretion) of discounts (premiums) related to these investments.
For the periods ended February 2, 2025 and October 31, 2024, the Company did
no
t have any unrealized gains or losses related to short-term investments.
NOTE 4
-
INVENTORIES
The components of
Inventories
at the balance sheet dates are presented below.
February 2,
2025
October 31,
2024
Raw materials
$
55,725
$
56,128
Work in process
1,856
398
Finished goods
2
1
$
57,583
$
56,527
NOTE 5 - PROPERTY, PLANT AND EQUIPMENT, NET
Presented below are the components of
Property, plant and equipment, net
at the balance sheet dates.
February 2,
2025
October 31,
2024
Land
$
11,144
$
11,419
Buildings and improvements
185,482
188,756
Machinery and equipment
1,991,605
1,990,610
Leasehold improvements
19,048
19,268
Furniture, fixtures, and office equipment
17,619
18,091
Construction in progress
79,488
91,213
2,304,386
2,319,357
Accumulated depreciation and amortization
(
1,554,577
)
(
1,574,100
)
$
749,809
$
745,257
Information on ROU assets resulting from finance leases, at the balance sheet dates, is presented below.
During the first quarter of 2025, the Company exercised its early buy-out option of one of the leased assets. Please refer to Note 7 for further information.
February 2,
2025
October 31,
2024
Machinery and equipment
$
7,253
$
42,815
Accumulated amortization
(
2,028
)
(
10,522
)
$
5,225
$
32,293
The following table presents depreciation expense (including the amortization of ROU assets), related to property, plant and equipment incurred during the reporting periods
.
Three Months Ended
February 2,
2025
January 28,
2024
Depreciation Expense
$
20,702
$
20,605
13
Table of Contents
NOTE 6 - PDMCX JOINT VENTURE
In January 2018, Photronics, Inc., through its wholly owned Photronics Singapore PTE. LTD. subsidiary (hereinafter, within this Note “we”, “Photronics”, “us”, or “our”), and DNP, through its wholly owned subsidiary “DNP Asia Pacific PTE, Ltd.”, entered into a joint venture under which DNP obtained a
49.99
% interest in the Company’s IC business in Xiamen, China. The joint venture, which the Company refers to as “PDMCX”, was established to develop and manufacture photomasks for semiconductors. The Company entered into this joint venture to enable the Company to compete more effectively for the merchant photomask business in China, and to benefit from the additional resources and investment that DNP provides to enable the Company to offer advanced-process technology to the Company’s customers.
Under the joint venture agreement,
should either Photronics’ or DNP’s
ownership interest fall below
20.0
% for a period of more than
six
consecutive months,
such party (an “exiting party”) has the option to sell to the other party, and the other party has the option to purchase from such exiting party, the exiting party’s remaining ownership interest
.
In either case
, the sales of ownership interests would be at the exiting party’s ownership percentage of the joint venture’s net book value, with closing to take place within
three
business days of obtaining required approvals and clearance.
The following table presents net income the Company recorded from the operations of PDMCX during the reporting periods.
Three Months Ended
February 2,
2025
January 28,
2024
Net income from PDMCX
$
3,368
$
6,463
As required by the guidance in ASC Topic 810 - “
Consolidation
”, the
Company evaluated
the Company’s involvement in PDMCX for the purpose of determining whether
the
Company should consolidate its results in
the Company’s
financial statements. The initial step of
the Company’s
evaluation was to determine whether PDMCX was a VIE. Due to its lack of sufficient equity at risk to finance its activities without additional subordinated financial support,
the
Company determined that it is a VIE. Having made this determination,
the
Company then assessed whether
the
Company was the primary beneficiary of the VIE and concluded that
the
Company was the primary beneficiary during the current and prior years reporting periods; thus, as required, the PDMCX financial results have been consolidated with Photronics.
The
Company’s conclusion was based on the fact that
the
Company held a controlling financial interest in PDMCX (which resulted from
the
Company’s having the power to direct the activities that most significantly impacted its economic performance) and had both the obligation to absorb losses and the right to receive benefits that could potentially be significant to PDMCX.
The
Company’s conclusion that
the
Company had the power to direct the activities that most significantly affected the economic performance of PDMCX during the current and prior year periods were based on
the
Company’s right to appoint the majority of its Board of Directors, which has, among others, the powers to manage the business (through its rights to appoint and evaluate PDMCX’s management), incur indebtedness, enter into agreements and commitments, and acquire and dispose of PDMCX’s assets. In addition, as a result of the
50.01
%
variable interest
the
Company held during the current and prior year periods,
the
Company had the obligation to absorb losses, and the right to receive benefits, which could potentially be significant to PDMCX.
The following table presents the carrying amounts of PDMCX assets and liabilities included in
the
Company’s consolidated balance sheets. General creditors of PDMCX do not have recourse to the assets of Photronics (other than the net assets of PDMCX); therefore,
the
Company’s maximum exposure to loss from PDMCX is
the
Company’s interest in the carrying amount of the net assets of the joint venture.
14
Table of Contents
February 2,
2025
October 31,
2024
Classification
Carrying
Amount
Photronics
Interest
Carrying
Amount
Photronics
Interest
Current assets
$
180,319
$
90,178
$
174,059
$
87,047
Noncurrent assets
146,679
73,354
151,039
75,535
Total assets
326,998
163,532
325,098
162,582
Current liabilities
40,215
20,112
40,691
20,350
Noncurrent liabilities
3,266
1,633
3,320
1,660
Total liabilities
43,481
21,745
44,011
22,010
Net assets
$
283,517
$
141,787
$
281,087
$
140,572
NOTE 7 - DEBT
The balance of the long-term debt and its current portion were comprised of the following finance leases as described below:
February 2,
2025
October 31,
2024
Principal due:
Next 12 months
$
2,631
$
17,972
Months 13 – 24
$
11
$
12
Months 25 – 36
10
12
Months 37 – 48
-
1
Months 49 – 60
-
-
Long-term debt
21
25
Total debt
$
2,652
$
17,997
Interest rate at balance sheet date
N/A
N/A
Basis spread on interest rates
N/A
N/A
Interest rate reset
N/A
N/A
Maturity date
N/A
N/A
Periodic payment amount
Varies as Lease matures
Varies as Lease matures
Periodic payment frequency
Monthly
Monthly
Loan collateral (carrying amount)
(1)
$
5,225
$
32,293
(1)
Represents the carrying amount at the balance sheet date of the related ROU assets, in which the lessors have secured interests.
Finance Leases
In February 2021, the Company entered into a
five-year
$
7.2
million finance lease for a high-end inspection tool. Monthly payments on the lease, which commenced in February 2021, are $
0.1
million per month. Upon the payment of the fiftieth monthly payment and prior to payment of the fifty-first monthly payment,
the Company
may exercise an early buyout option to purchase the tool for $
2.4
million.
After the original term or any renewal periods,
the Company
may return the tool, elect to extend the lease, or purchase the tool at its fair market value. Management has determined that the Company will exercise its early buyout option during the first half of 2025.
15
Table of Contents
In December 2020, the Company entered into a
five-year
$
35.5
million finance lease for a high-end lithography tool. Monthly payments on the lease, which commenced in January 2021, increased from $
0.04
million during the first three months to $
0.6
million for the following nine months, followed by forty-eight monthly payments of $
0.5
million.
The lease agreement provides an early buyout option to purchase the tool for $
14.1
million, which the
Company exercised during the first quarter of fiscal year 2025
.
Xiamen Working Capital Loans
In November 2018, PDMCX obtained approval for revolving, unsecured credit of CNY
200
million ($
25
million), pursuant to which PDMCX may enter into separate loan agreements with varying terms to maturity. In December 2022, the Company repaid the Company’s entire outstanding balance of CNY
25.6
million ($
3.6
million).
The interest rates are variable, based on the CNY Loan Prime Rate of the National Interbank Funding Center. Interest incurred on the loans
related to the amount borrowed
was eligible for reimbursement through incentives provided by the Xiamen Torch Hi-Tech Industrial Development Zone, which provided for such reimbursements up to a prescribed limit and duration.
This facility is subject to annual reviews and extensions. In August 2024, the Company was issued an extension to the revolving, unsecured credit agreement for CNY
200
million (approximately $
27.7
million) with an expiration date of
July 31, 2025
.
As of February 2, 2025, PDMCX had
no
outstanding borrowings against the approval
.
NOTE 8 - REVENUE
The Company recognizes
revenue when, or as, control of a good or service transfers to a customer, in an amount that reflects the consideration to which the Company expects to be entitled in exchange for transferring those goods or services.
The Company
accounts for an arrangement as a revenue contract when each party has approved and is committed to perform under the contract, the rights of the contracting parties regarding the goods or services to be transferred and the payment terms are identifiable, the arrangement has commercial substance, and collection of consideration is probable. Substantially all of
the Company
’s revenue comes from the sales of photomasks.
The Company
typically contracts with the Company’s customers to sell sets of photomasks, which are comprised of multiple layers, the predominance of which
the Company
invoices as they ship to customers. As the photomasks are manufactured to customer specifications, they have
no
alternative use to
the Company
and, as
the Company’s
contracts generally provide
the Company
with the right to payment for work completed to date,
the Company recognizes
revenue as
the Company
performs, or “over time,” on most of
the Company’s
contracts.
The Company measures the Company’s
performance to date using an input method, which is based on the Company’s estimated costs to complete the various manufacturing phases of a photomask. At the end of a reporting period, there are a number of uncompleted revenue contracts on which
the Company has
performed; for any such contracts under which
the Company is
entitled to be compensated for
the Company’s
costs incurred plus a reasonable profit,
the Company recognizes
revenue and a corresponding contract asset for such performance.
The Company
accounts for shipping and handling activities that
the Company
performs after a customer obtains control of a good as being activities to fulfill
the Company’s
promise to transfer the good to the customer, rather than as promised services, or performance obligations, under the contract.
The Company reports the Company’s
revenue net of any sales or similar taxes
the Company
collects on behalf of governmental entities.
As stated above, photomasks are manufactured to customer specifications in accordance with their proprietary designs; thus, they are individually unique. Due to their uniqueness and other factors, their transaction prices are individually established through negotiations with customers; consequently, the Company’s photomasks do not have standard or “list” prices. The transaction prices of the vast majority of the Company’s revenue contracts include only fixed amounts of consideration. In certain instances, such as when the Company offers a customer an early payment discount, an estimate of variable consideration would be included in the transaction price, but only to the extent that a significant reversal of revenue would not occur when the uncertainty related to the variability was resolved.
16
Table of Contents
Contract Assets and Contract Liabilities
The Company recognizes
a contract asset when the Company’s performance under a contract precedes the Company’s receipt of consideration from a customer, or before payment is due, and the Company’s receipt of consideration is conditional upon factors other than the passage of time. Contract assets reflect the Company’s transfer of control to customers of photomasks that are in process or completed but not yet shipped to customers. A receivable is recognized when the Company has an unconditional right to payment for the Company’s performance, which generally occurs when the Company ships the photomasks. The Company’s contract assets primarily consist of a significant amount of the Company’s in-process production orders and fully manufactured photomasks which have not yet shipped, for which the Company has an enforceable right to collect consideration (including a reasonable profit) in the event the in-process orders are cancelled by customers. On an individual contract basis, the Company nets contract assets with contract liabilities (deferred revenue) for financial reporting purposes. The Company’s net credit losses on accounts receivable during the periods ended February 2, 2025 and January 28, 2024 were immaterial. The Company did
no
t impair any contract assets or accounts receivable during the
three
-month periods ended February
2, 2025,
or
January 28, 2024
.
The following table provides information about the Company’s contract balances at the balance sheet dates.
Classification
February 2,
2025
October 31,
2024
Contract Assets
Other current assets
$
11,819
$
11,532
Contract Liabilities
Accrued liabilities
$
10,887
$
12,375
Other liabilities
7,813
8,910
$
18,700
$
21,285
The Company did
no
t recognize any revenue from performance obligations satisfied in the previous periods.
The following table presents revenue recognized from contract liabilities that existed at the beginning of the reporting periods.
Three Months Ended
February 2,
2025
January 28,
2024
Revenue recognized from beginning liability
$
4,369
$
5,507
The Company generally records accounts receivable at their billed amounts. All outstanding past due customer invoices are reviewed for collectability during, and at the end of, every reporting period. To the extent the Company believes a loss on the collection of a customer invoice is probable, the Company would record the loss and credit an allowance for credit losses. In the event that an amount is determined to be uncollectible,
the Company
charges the allowance for credit losses and derecognizes the related receivable. The Company did
no
t incur any credit losses on the Company’s accounts receivable during the three-month periods ended February 2, 2025,
or
January 28, 2024.
The Company’s invoice terms generally range from net
thirty
to
ninety days
, depending on both the geographic market in which the transaction occurs and the Company’s payment agreements with specific customers. In the event that
the Company’s
evaluation of a customer’s business prospects, and financial condition indicate that the customer presents a collectability risk, the Company will modify terms of sale, which may require payment in advance of performance. At the time of adoption,
the Company
elected the practical expedient allowed under ASC Topic
606
“Revenue from Contracts with Customers” (“Topic
606
”) that permits
the Company
not to adjust a contract’s promised amount of consideration to reflect a financing component when the period between when
the Company
transfers control of goods or services to customers and when
the Compan
y is paid is
one
year or less.
17
Table of Contents
In instances when
the Company
is paid in advance of
the Company’s
performance,
the Company
records a contract liability and, as allowed under the practical expedient in Topic
606
, recognizes interest expense only if the period between when
the Company
receives payment from the customer and the date when
the Company
expects to be entitled to the payment is greater than
one
year. Historically, advance payments
the Company has
received from customers have generally not preceded the completion of
the Company’s
performance obligations by more than
one
year.
Disaggregation of Revenue
The following tables present
the Company’s
revenue for the
three
-month periods ended
February 2, 2025,
and
January 28, 2024
, disaggregated by product type, geographic origin, and timing of recognition.
Three Months Ended
Revenue by Product Type
February 2,
2025
January 28,
2024
IC
High-end
$
60,105
$
60,875
Mainstream
93,851
96,714
Total IC
$
153,956
$
157,589
FPD
High-end
$
49,679
$
50,616
Mainstream
8,503
8,129
Total FPD
$
58,182
$
58,745
$
212,138
$
216,334
Three Months Ended
February 2,
2025
January 28
,
2024
Revenue by Geographic Origin*
Taiwan
$
73,035
$
74,965
China
53,558
58,137
South Korea
40,237
40,335
United States
36,898
32,733
Europe
7,940
9,705
Other
470
459
$
212,138
$
216,334
*
This table disaggregates revenue by the location in which it was earned.
Three Months Ended
February 2,
January 28,
Revenue by Timing of Recognition
2025
2024
Over time
$
205,076
$
203,527
At a point in time
7,062
12,807
212,138
216,334
Contract Costs
The Company pays commissions to third-party sales agents for certain sales they procure on the Company’s behalf. However, the bases of the commissions are the transaction prices of the sales, which are completed in less than one year; thus, no relationship is established with a customer that will result in future business. Therefore, the Company does not recognize any portion of these sales commissions as costs of obtaining a contract, nor does the Company currently foresee other circumstances under which the Company would recognize contract obtainment costs as assets.
18
Table of Contents
Remaining Performance Obligations
As the Company is typically required to fulfill customer orders within a short time period, the Company’s backlog of orders is generally not in excess of
one
to
two weeks
for IC photomasks and
two
to
three weeks
for FPD photomasks. However, the demand for some IC photomasks can extend beyond the traditional time period; thus, the backlog, in some individual cases, can extend to as long as
two
to
three months
.
More recently however, backlogs for most high demand products have returned to historical levels of less than a month.
As allowed under ASC 606 –
Revenue Contracts with Customers
,
the Company has
elected not to disclose the Company’s remaining performance obligations, which represent the costs associated with the completion of the manufacturing process of in-process photomasks related to contracts that have an original duration of one year or less.
Product Warranties
The Company’s photomasks are sold under warranties that generally range from
one
to
twenty-four months
. The Company warrants that the Company’s photomasks conform to customer specifications, and the Company will typically repair, replace, or issue a refund for any photomasks that fail to do so. The warranties do not represent separate performance obligations in the Company’s revenue contracts. Historically, customer claims under warranties have been immaterial.
NOTE 9 - SHARE-BASED COMPENSATION
In March 2016, shareholders approved the Company’s current equity incentive compensation plan (the “Plan”), under which incentive stock options, non-qualified stock options, stock grants, stock-based awards, restricted stock, restricted stock units, stock appreciation rights, performance units, performance stock, and other stock or cash awards may be granted. Shares to be issued under the Plan may be authorized and unissued shares, issued shares that have been reacquired by the Company (in the open market or in private transactions), or a combination thereof. The original maximum number of shares of common stock approved that may be issued under the Plan was
four
million shares.
On March 16, 2023, at its annual meeting of shareholders, the shareholders of Photronics, Inc., approved amendments to the Plan to increase the number of shares available for issuance by an additional
one
million shares, thereby increasing the shares available for issuance under the Plan from
four
million to
five
million.
Awards may be granted to officers, employees, directors, consultants, advisors, and independent contractors of Photronics or its subsidiaries. In the event of a change in control (as defined in the Plan), the vesting of awards may be accelerated. The Plan prohibits further awards from being issued under prior plans.
The table below presents information on the Company’s share-based compensation expenses.
Three Months Ended
February 2,
2025
January 28,
2024
Expense reported in:
Cost of goods sold
$
776
$
595
Selling, general, and administrative
2,268
1,749
Research and development
290
229
Total expense incurred
$
3,334
$
2,573
Expense by award type:
Restricted stock awards
$
3,277
$
2,573
Employee stock purchase plan
57
-
Total expense incurred
$
3,334
$
2,573
Income tax benefits on share-based compensation
$
446
$
99
19
Table of Contents
Restricted Stock Awards
The Company periodically grants restricted stock awards, the restrictions on which typically lapse over a service period of
one
to
four years
. The fair value of the awards is determined on the date of grant, based on the closing price of the Company’s common stock.
The table below presents information on the Company’s restricted stock awards.
Three Months Ended
February 2,
2025
January 28,
2024
Number of shares granted in period
345,500
825,050
Weighted-average grant-date fair value of awards (in dollars per share)
$
23.82
$
29.77
Compensation cost not yet recognized
$
25,786
$
31,426
Weighted-average amortization period for cost not yet recognized (in years)
3.0
3.3
Shares outstanding at balance sheet date
1,256,697
1,634,315
Stock Options
Option awards generally vest in
one
to
four years
and have a
ten-year
contractual term. All incentive and non-qualified stock option grants must have an exercise price no less than the market value of the underlying common stock on the date of grant. The grant-date fair values of options are based on closing prices of the Company’s common stock on the dates of grant and are calculated using the Black-Scholes option pricing model. Expected volatility is based on the historical volatility of the Company’s common stock. The Company uses historical option exercise behavior and employee termination data to estimate expected term, which represents the period of time that options are expected to remain outstanding. The risk-free rate of return for the estimated term of an option is based on the U.S. Treasury yield curve in effect at the date of grant.
The table below presents information on the Company’s stock options.
Three Months Ended
February 2,
2025
January 28,
2024
Number of options granted in period
-
-
Cash received from options exercised
$
1,272
$
936
Compensation cost not yet recognized
$
-
$
-
Weighted-average amortization period for cost not yet recognized (in years)
-
-
Information regarding outstanding and exercisable option awards as of February 2, 2025, is presented below.
Options
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (in years)
Aggregate
Intrinsic
Value
Outstanding and exercisable at
February 2, 2025
150,325
$
10.73
2.05
$
1,843
20
Table of Contents
NOTE 10 - INCOME TAXES
The Company calculates its provision for income taxes at the end of each interim reporting period on the basis of an estimated annual effective tax rate adjusted for tax items that are discrete to each period.
The table below sets forth the primary reasons that the Company’s effective income tax rates differed from the U.S. statutory tax rates in effect during the three-month periods ended February
2, 2025, and January 28, 2024.
Reporting Period
U.S. Statutory
Tax Rates
Photronics
Effective Tax
Rates
Primary Reasons for Differences
Three months ended February 2, 2025
21.0
%
24.5
%
Non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, non-U.S. pre-tax income being taxed at higher statutory rates in the non-U.S. jurisdictions, and the establishment of uncertain tax positions in non-U.S. jurisdictions.
Three months ended January 28, 2024
21.0
%
27.3
%
Non-recognition of the tax benefit of losses that, in certain jurisdictions, have been offset by valuation allowances, non-U.S. pre-tax income being taxed at higher statutory rates in the non-U.S. jurisdictions and the establishment of uncertain tax positions in non-U.S. jurisdictions.
Uncertain Tax Positions
Although the timing of reversal of uncertain tax positions may be uncertain, as they can be dependent upon the settlement of tax audits, we believe that the amount of uncertain tax positions (including interest and penalties, and net of tax benefits) that may be resolved over the next twelve months is immaterial. Resolution of these uncertain tax positions may result from either or both the lapses of statutes of limitations and tax settlements. We are no longer subject to tax authority examinations in the U.S., major foreign, or state tax jurisdictions for years prior to fiscal year
2019
.
The table below presents information on our unrecognized tax benefits as of the balance sheet dates.
February 2,
2025
October 31,
2024
Unrecognized tax benefits related to uncertain tax positions
$
16,616
$
14,720
Unrecognized tax benefits that, if recognized, would impact the effective tax rate
$
16,616
$
14,720
Accrued interest and penalties related to uncertain tax positions
$
1,174
$
1,028
21
Table of Contents
NOTE 11 - EARNINGS PER SHARE
The following sets forth the computation of basic and diluted earnings per share:
Three Months Ended
February 2,
2025
January 28,
2024
Net income attributable to Photronics, Inc. shareholders
$
42,851
$
26,180
Weighted-average common shares outstanding (in thousands):
Basic
62,093
61,455
Effect of dilutive securities:
Share-based awards
568
828
Dilutive common shares
568
828
Weighted-average common shares - Diluted
62,661
62,283
Earnings per share attributable to Photronics, Inc. shareholders:
Basic
$
0.69
$
0.43
Diluted
$
0.68
$
0.42
The table below illustrates the outstanding weighted-average share-based awards that were excluded from the calculation of diluted earnings per share because their exercise price exceeded the average market value of the common shares for the period or, under application of the treasury stock method, they were otherwise determined to be antidilutive
.
Three Months Ended
February 2,
2025
January 28,
2024
Share-based awards
488
241
Total potentially dilutive shares excluded
488
241
NOTE 12 - COMMITMENTS AND CONTINGENCIES
As of February 2, 2025, the Company’s unrecognized unconditional purchase obligations, which are mainly payments for the acquisition of property, plant and equipment, with a remaining term in excess of
one year
was approximately $
82.8
million, primarily for purchases of high-end equipment. This amount does not include the Company’s commitments under the Company’s debt and lease arrangements.
The Company is subject to various other claims that arise in the ordinary course of business. The Company believes that the Company’s potential liability under such claims, individually or in the aggregate, will not have a material effect on the Company’s consolidated financial statements.
22
Table of Contents
NOTE 13 - CHANGES IN ACCUMULATED OTHER COMPREHENSIVE (LOSS) INCOME BY COMPONENT
The following tables set forth the changes in the Company’s accumulated other comprehensive (loss) income by component (net of tax) for the three-month periods ended February 2, 2025, and January 28, 2024.
Three Months Ended February 2, 2025
Foreign Currency
Translation
Adjustments
Other
Total
Balance at October 31, 2024
$
(
85,587
)
$
(
732
)
$
(
86,319
)
Other comprehensive (loss) income
(
42,917
)
70
(
42,847
)
Other comprehensive income (loss) attributable to noncontrolling interests
8,875
(
34
)
8,841
Balance at
February 2, 2025
$
(
119,629
)
$
(
696
)
$
(
120,325
)
Three Months Ended January 28, 2024
Foreign Currency
Translation
Adjustments
Other
Total
Balance at October 31, 2023
$
(
88,044
)
$
(
690
)
$
(
88,734
)
Other comprehensive (loss) income
31,493
(
27
)
31,466
Other comprehensive (loss) income attributable to noncontrolling interests
(
10,609
)
14
(
10,595
)
Balance at
January 28, 2024
$
(
67,160
)
$
(
703
)
$
(
67,863
)
NOTE 14 - SHARE REPURCHASE PROGRAMS
In September 2020, the Company’s Board of Directors authorized the repurchase of up to $
100
million of its common stock, pursuant to a repurchase plan under Rule 10b-18 of the Exchange Act. The repurchase authorization by the Board of Directors has no expiration date, does not obligate the Company to acquire any common stock, and is subject to market conditions. From September 2020 through October 2022, the Company repurchased
5.8
million shares at a cost of $
68.3
million. In August 2024, the Board of Directors authorized an increase to the Company’s existing share repurchase program from the remaining $
31.7
million up to $
100
million. During the three-month period ended February 2, 2025, the Company repurchased
195,079
shares at a cost of $
4.6
million pursuant to Rule 10b-18 of the Exchange Act. All shares repurchased under the program have been retired. As of February 2, 2025, $
95.4
million remained available under this authorization for the repurchase of additional shares.
23
Table of Contents
Item 2.
MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
Overview
Management’s discussion and analysis (“MD&A”) of the Company’s financial condition and results of operations should be read in conjunction with its condensed consolidated financial statements and related notes. Various sections of this MD&A contain forward-looking statements, all of which are presented based on current expectations, which may be adversely affected by uncertainties and risk factors (presented throughout this filing and in the Company’s Form 10-K for fiscal year 2024), that may cause actual results to materially differ from these expectations. See “Forward-Looking Statements”.
We sell substantially all of our photomasks to semiconductor designers and manufacturers, and manufacturers of FPDs. Photomask technology is also being applied to the fabrication of other higher-performance electronic products such as photonics, microelectronic mechanical systems, and certain nanotechnology applications. Our selling cycle is tightly interwoven with the development and release of new semiconductor and display designs and applications, particularly as they relate to the semiconductor industry’s migration to more advanced product innovation, design methodologies, and fabrication processes. The demand for photomasks primarily depends on design activity rather than sales volumes from products manufactured using photomask technologies. Consequently, an increase in semiconductor or display sales does not necessarily result in a corresponding increase in photomask sales. However, the reduced use of customized ICs, reductions in design complexity, other changes in the technology or methods of manufacturing or designing semiconductors, or a slowdown in the introduction of new semiconductor or display designs could reduce demand for photomasks ‒ even if the demand for semiconductors and displays increases. Advances in semiconductor, display, and photomask design and production methods that shift the burden of achieving device performance away from lithography could also reduce the demand for photomasks. Historically, the microelectronics industry has been volatile, experiencing periodic downturns and slowdowns in design activity. These negative trends have been characterized by
, among other things, diminished product demand, excess production capacity, and accelerated erosion of selling prices, with a concomitant effect on revenue and profitability.
We are typically required to fulfill customer orders within a short period of time, sometimes within twenty-four hours. This results in a minimal level of backlog, typically two to three weeks of backlog for FPD photomasks and one to two weeks for IC photomasks. However, the demand for some IC photomasks has in the past expanded beyond the industry’s capacity to supply them within the traditional time period; thus, for some products, the backlog can expand to as long as two to three months.
The global semiconductor and FPD industries are driven by end markets which have been closely tied to consumer-driven applications of high-performance devices, including, but not limited to, mobile display devices, mobile communications, and computing solutions. While we cannot predict the timing of the industry’s transition to volume production of next-generation technology nodes, or the timing of up and down-cycles with precise accuracy, we believe that such transitions and cycles will continue into the future, beneficially and adversely affecting our business, financial condition, and operating results as they occur. We believe our ability to remain successful in these environments is dependent upon the achievement of our goals of being a service and technology leader and efficient solutions supplier, which we believe should enable us to continually reinvest in our global infrastructure.
23
Table of Contents
Results of Operations
The following tables present selected operating information expressed as a percentage of revenue. The columns may not foot due to rounding.
Three Months Ended
February 2,
2025
October 31,
2024
January 28,
2024
Revenue
100
%
100.0
%
100.0
%
Cost of goods sold
64.4
63.0
63.4
Gross profit
35.6
37.0
36.6
Operating expenses:
Selling, general, and administrative
9.0
9.4
8.5
Research and development
2.0
2.4
1.6
Operating income
24.6
25.2
26.6
Other income (expense), net
11.8
(0.5
)
(1.7
)
Income before income tax provision
36.4
24.7
24.8
Income tax provision
8.9
6.5
6.8
Net income
27.5
18.2
18.1
Net income attributable to noncontrolling interests
7.3
2.9
6.0
Net income attributable to Photronics, Inc. shareholders
20.2
%
15.3
%
12.1
%
Note:
All the following tabular comparisons, unless otherwise indicated, are for the three months ended February 2, 2025 (Q1 FY25), October 31, 2024 (Q4 FY24) and January 28, 2024 (Q1 FY24). The tables in this item may not foot due to rounding.
Revenue
Our quarterly revenues can be affected by the seasonal purchasing practices of our customers. As a result, demand for our products is typically reduced during the first quarter of our fiscal year by the North American, European, and Asian holiday periods, as some of our customers reduce their development and, consequently, their buying activities during those periods.
24
Table of Contents
The following tables present changes in revenue disaggregated by product type and geographic origin, in Q1 FY25 from revenue in prior reporting periods.
Quarterly Changes in Revenue by Product Type ($ in millions)
Q1 FY25 compared with Q4 FY24
Q1 FY25 compared with Q1 FY24
Revenue in
Q1 FY25
Increase
(Decrease)
Percent
Change
Increase
(Decrease)
Percent
Change
IC
High-end *
$
60.1
$
0.1
0.1
%
$
(0.8
)
(1.3
)%
Mainstream
93.9
(9.9
)
(9.5
)%
(2.9
)
(3.0
)%
Total IC
$
154.0
$
(9.8
)
(6.0
)%
$
(3.7
)
(2.3
)%
FPD
High-end *
$
49.7
$
1.3
2.7
%
$
(0.9
)
(1.9
)%
Mainstream
8.5
(2.0
)
(19.0
)%
0.4
4.6
%
Total FPD
$
58.2
$
(0.7
)
(1.2
)%
$
(0.5
)
(1.0
)%
Total Revenue
$
212.1
$
(10.5
)
(4.7
)%
$
(4.2
)
(1.9
)%
* High-end photomasks typically have higher ASPs than mainstream products.
Quarterly Changes in Revenue by Geographic Origin ($ in millions) **
Q1 FY25 compared with Q4 FY24
Q1 FY25 compared with Q1 FY24
Revenue in
Q1 FY25
Increase
(Decrease)
Percent
Change
Increase
(Decrease)
Percent
Change
Taiwan
$
73.0
$
3.3
4.8
%
$
(1.9
)
(2.6
)%
China
53.6
(7.3
)
(11.9
)%
(4.6
)
(7.9
)%
South Korea
40.2
0.3
0.6
%
(0.1
)
(0.2
)%
United States
36.9
(4.9
)
(11.7
)%
4.2
12.7
%
Europe
7.9
(1.9
)
(19.4
)%
(1.8
)
(18.2
)%
Other
0.5
-
(4.3
)%
-
2.4
%
Total revenue
$
212.1
$
(10.5
)
(4.7
)%
$
(4.2
)
(1.9
)%
** This table disaggregates revenue by the location in which it was earned.
Revenue in Q1 FY25 of $212.1 million represented a decrease of 4.7 % compared with Q4 FY24 primarily due to seasonal softness, and a decrease of 1.9% from Q1 FY24, due to mainstream weakness in Asia and Europe.
IC revenue decreased $9.8 million or 6.0% in Q1 FY25 from Q4 FY24 primarily due to a decrease in mainstream of $9.9 million or 9.5% as a result of the overall softness of semiconductor industry. Comparing Q1 FY25 to Q1 FY24, IC revenue decreased $3.7 million or 2.3% mainly due to reduced demand in Asia and Europe.
FPD revenue decreased $0.7 million or 1.2% in Q1 FY25 from Q4 FY24 and $0.5 million or 1.0% from Q1 FY24 as a result of industry softness.
25
Table of Contents
Gross Margin ($ in millions)
Q1 FY25
Q4 FY24
Percent
Change
Q1 FY24
Percent
Change
Gross profit
$
75.5
$
82.3
(8.2
)%
$
79.3
(4.7
)%
Gross margin
35.6
%
37.0
%
36.6
%
Gross margin decreased by 140 basis points in Q1 FY25 as compared to Q4 FY24, primarily as a result of the decrease in revenue of 4.7%, partially offset by a decrease in material costs of 2.5%, or 55 basis points as a percentage of revenue and a decrease in equipment and other costs of goods sold of 5.0%, or 9 basis points as a percentage of revenue.
Gross margin decreased by 100 basis points in Q1 FY25, from Q1 FY24, primarily as a result of the decrease in revenue of 1.9%, partially offset by a decrease in material costs of 2.7%, or 16 basis points as a percentage of revenue and a decrease in Labor and Benefits of 2.8%, or 10 basis points as a percentage of revenue.
Selling, General and Administrative Expenses
Selling, general and administrative expenses were $19.1 million in Q1 FY25, compared with $21.0 million in Q4 FY24, and $18.3 million in Q1 FY24. The $1.9 million decrease from Q4 FY24 was primarily the result of compensation and related expenses of $0.9 million and professional fees of $0.7 million. The $0.8 million increase from Q1 FY24 was primarily the result of increased professional fees of $0.5 million.
Research and Development Expenses
Research and development expenses, which primarily consist of development and qualification efforts related to process technologies for high-end IC and FPD applications, decreased $1.0 million to $4.3 million in Q1 FY25 from Q4 FY24; the decrease was primarily caused by reduced qualification activities in Asia. Research and development expenses in Q1 FY25 increased by $0.8 million from Q1 FY24 as a result of increased development activities in the U.S.
Other Income (Expense) ($ in millions)
Q1 FY25
Q4 FY24
Q1 FY24
Foreign currency transactions impact, net
$
18.4
$
(7.7
)
$
(8.9
)
Interest expense, net
(0.0
)
(0.1
)
(0.1
)
Interest income and other income, net
6.6
6.8
5.3
Other Income (expense), net
$
25.0
$
(1.0
)
$
(3.7
)
Other Income (expense) increased in Q1 FY25 from Q4 FY24 by $26.0 million and from Q1 FY24 by $28.7 million, primarily due to foreign currency impacts. The foreign currency impacts were primarily driven by favorable movements of the New Taiwan dollar and the South Korean won, against the U.S. dollar.
Income Tax Provision ($ in millions)
Q1 FY25
Q4 FY24
Q1 FY24
Income tax provision
$
18.9
$
14.6
$
14.7
Effective income tax rate
24.5
%
26.6
%
27.3
%
On December 15, 2022, the European Union (EU) Member States formally adopted the EU’s Pillar Two Directive, which generally provides for a minimum effective tax rate of 15%, as established by the Organization for Economic Co-operation and Development (OECD) Pillar Two Framework. The EU effective dates are January 1, 2024, and January 1, 2025, for different aspects of the directive. A significant number of other countries are expected to also implement similar legislation with varying effective dates. The Company is currently subject to Pillar Two, but we estimate that the financial impact is immaterial. We will continuously evaluate the potential impact of the Pillar Two Framework to ensure we are compliant in the future.
26
Table of Contents
The effective income tax rate is sensitive to the jurisdictional mix of earnings, due in part to the non-recognition of tax benefits on losses in jurisdictions with valuation allowances.
The effective income tax rate decrease in Q1 FY25, compared with Q4 FY24, is primarily due to changes in the jurisdictional mix of earnings and a decrease in foreign taxes in Q1 FY25.
The effective income tax rate decrease in Q1 FY25, compared with Q1 FY24, is primarily due to changes in the jurisdictional mix of earnings and a decrease in foreign taxes in Q1 FY25.
Net Income Attributable to Noncontrolling Interests
Net income attributable to noncontrolling interests was $15.4 million in Q1 FY25, compared with $6.4 million in Q4 FY24; the increase was the result of a net increase in the net income of the Company’s joint venture operations. Net income attributable to noncontrolling interests increased by $2.5 million in Q1 FY25 from Q1 FY24, as a result of increased net income at the Company’s Taiwan-based IC facilities.
Liquidity and Capital Resources
Cash and cash equivalents were $642.2
million and $598.5 million as of February 2, 2025, and October 31, 2024, respectively. During Q1 2025 all our short-term investments matured. As of February 2, 2025, total cash and cash equivalents included $550.2
million held by foreign subsidiaries, including an aggregate of $366.8 million held by our joint ventures in Taiwan and China. In addition, we currently have CNY 200 million (approximately $27.7 million) of borrowing capacity in China to support local operations. See Note 7
– Debt
to the consolidated financial statements for additional information on the Company’s outstanding debt and currently available financing. The Company’s primary sources of liquidity are the Company’s cash on hand and cash we generate from operations.
We continually evaluate alternatives for efficiently funding the Company’s capital expenditures and ongoing operations. These reviews may result in the Company’s engagement in a variety of investing and financing transactions, in the transfer of cash among subsidiaries, and/or the repatriation of cash to the U.S. The transfer of funds among subsidiaries could be subject to foreign withholding taxes; in certain jurisdictions, repatriation of these funds to the U.S. may subject them to U.S. state income taxes and/or local country withholding taxes. We believe that the Company’s liquidity, including available financing, is sufficient to meet the Company’s requirements through the next twelve months and thereafter for the foreseeable future. Through the utilization of the Company’s existing liquidity, cash we generate from operations and short-term investments, we plan to continue to invest in the Company’s business, with the Company’s investments targeted to align with the Company’s customers’ technology road maps. In addition, we stand ready to invest in mergers, acquisitions, or strategic partnerships, should a suitable opportunity arise.
We estimate capital expenditures for the Company’s fiscal year 2025 will be approximately $200 million mainly in Asia and the U.S.; these investments will be targeted towards high-end and mainstream capacity that will increase the Company’s operating capability and efficiency and enable us to support the Company’s customers’ near-term demands. As of February 2, 2025, we had outstanding capital commitments of approximately $170.3 million and accrued liabilities related to capital equipment purchases of approximately $13.9 million. Although payment timing could vary, primarily as a result of the timing of tool delivery, installation and testing, we currently estimate that we will fund $175.4 million of the Company’s total $184.2 million committed and recognized obligations for capital expenditures over the next twelve months.
On August 28, 2024, the Board of Directors authorized an increase to the Company’s existing share repurchase program from the remaining $31.7 million to $100 million. During Q1 FY25, the Company repurchased 195,079 shares for $4.6 million. As of February 2, 2025, there was $95.4 million remaining under the August 28, 2024 authorization. Depending on market conditions, we may utilize some or the entire remaining approved amount to reacquire additional shares.
27
Table of Contents
As discussed in Note 6
– PDMCX Joint Venture
of the Company’s consolidated financial statements, DNP, the noncontrolling interest in the Company’s China-based joint venture has, under certain circumstances, the right to put its interest in the joint venture to Photronics, or to purchase the Company’s interest in the joint venture. Under all such circumstances, the sale of DNP’s interest would be at its ownership percentage of the joint venture’s net book value, with closing to take place within three business days of obtaining required approvals and clearance. As of the date of issuance of this report, DNP had not indicated its intention to exercise this right. As of February 2, 2025, Photronics and DNP each had net investments in this joint venture of approximately $141.8
million.
Cash Flows
Q1 FY25
Q1 FY24
Net cash provided by operating activities
$
78.5
$
41.5
Net cash provided by (used in) investing activities
$
6.8
$
(42.2
)
Net cash used in financing activities
$
(20.5
)
$
(2.9
)
Operating Activities
:
Net cash provided by operating activities
reflects net income adjusted for certain non-cash items, including depreciation and amortization, share-based compensation, and the effects of changes in operating assets and liabilities. Net cash provided by operating activities increased by $37.0 million in the first quarter of FY25, compared with the same period of FY24, primarily due to increased net cash-favorable changes in working capital, predominantly in Asia.
Investing Activities
: Net cash flows provided by investing activities increased by $49.0 million in the first quarter of FY25, compared to the cash flows used in investing activities in the same period of FY24, primarily driven by an additional maturity of short-term investments of $39.0 million, partially offset by a decrease of purchases of property, plant and equipment of $8.1 million.
Financing Activities
: Net cash used in financing activities increased by $17.6 million in the first quarter FY25, compared to the same period of FY24. This was primarily driven by an increase in debt repayment of $14.1 million and share repurchase of $4.6 million.
The Company’s cash, cash equivalents, and restricted cash balances were negatively impacted by changes in foreign currency exchange rates during the first quarter of FY25 by $34.2
million.
Non-GAAP Financial Measures
Non-GAAP Net Income attributable to Photronics, Inc. shareholders and non-GAAP diluted earnings per share are “non-GAAP financial measures” as such term is defined by Regulation G of the Securities and Exchange Commission and may differ from similarly named non-GAAP financial measures used by other companies. The financial tables below reconcile Photronics, Inc. financial results under U.S. GAAP to our non-GAAP financial information. We believe these non-GAAP financial measures that exclude certain items are useful for analysts and investors to evaluate the Company’s on-going performance because they enable a more meaningful comparison of historical results of the Company’s core business. These non-GAAP metrics are not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to Net income (loss), Net income (loss) per share, or any other measure of consolidated results under U.S. GAAP. The items excluded from these non-GAAP metrics but included in the calculation of their closest U.S. GAAP equivalent, are significant components of the condensed consolidated statement of income and must be considered in performing a comprehensive assessment of overall financial performance.
28
Table of Contents
The following table reconciles
U.S.
GAAP to Non-GAAP Income
for the indicated periods. The columns may not foot due to rounding.
Three Months ended
Feb 2,
2025
Oct 31,
2024
Jan 28,
2024
Reconciliation of U.S. GAAP to Non-GAAP Net Income:
U.S. GAAP Net Income attributable to Photronics, Inc. shareholders
$
42,851
$
33,869
$
26,180
FX loss (gain)
(18,443
)
7,758
8,909
Estimated tax effects of above
5,152
(1,936
)
(2,244
)
Estimated noncontrolling interest effects of above
2,823
(2,637
)
(2,939
)
Non-GAAP Net Income attributable to Photronics, Inc. shareholders
32,383
$
37,054
$
29,906
Weighted-average number of common shares outstanding - Diluted
62,661
62,456
62,283
Reconciliation of U.S. GAAP to Non-GAAP EPS:
U.S. GAAP diluted earnings per share
$
0.68
$
0.54
$
0.42
Effects of the above non-GAAP adjustments
(0.16
)
0.05
0.06
Non-GAAP diluted earnings per share
$
0.52
$
0.59
$
0.48
Business Outlook
Our current business outlook and guidance was provided in the Photronics Q1 FY25 earnings release, earnings presentation, and financial results conference call, but is not incorporated herein. These can be accessed in the investor section of our website -
www.photronics.com. Information included on our website is not incorporated in this Form 10-Q.
Our future results of operations and the other forward-looking statements contained in this filing and in the Photronics Q1 FY25 earnings release, and the related financial results conference call and earnings presentation involve a number of risks and uncertainties, some of which were discussed in Part I, Item 1A of our 2024 Form 10-K. These factors and a number of other unforeseeable factors could cause actual results to differ materially from our expectations.
Critical Accounting Estimates
Please refer to Part II, Item 7 of our 2024 Form 10-K for discussion of our critical accounting estimates. There have been no changes to our critical accounting estimates since the filing of our Form 10-K for the year ended October 31, 2024.
Item 3.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
Foreign Currency Exchange Rate Risk
We conduct business in several major currencies throughout our worldwide operations, and our financial performance may be affected by fluctuations in the exchange rates of these currencies. Changes in exchange rates can positively or negatively affect our reported revenue, operating income, assets, liabilities, and equity. The functional currencies of our Asian subsidiaries are the South Korean won, the New Taiwan dollar, the Chinese yuan, and the Singapore dollar. The functional currencies of our European subsidiaries are the British pound and the euro. In addition, we engage in transactions and have exposures to the Japanese yen.
29
Table of Contents
We attempt to minimize our risk of foreign currency transaction losses by producing products in the same country in which the products are sold (thereby generating revenues and incurring expenses in the same currency), and by managing our working capital. However, in some instances, we sell products in a currency other than the functional currency of the entity where it was produced, or purchase products in a currency that differs from the functional currency of the purchasing entity. We may also enter into derivative contracts to mitigate our exposure to foreign currency fluctuations when we have a significant purchase obligation or significant receivable denominated in a currency that differs from the functional currency of the transacting subsidiary. We do not enter into derivatives for speculative purposes. There can be no assurance that this approach will protect us from the need to recognize significant foreign currency transaction gains and losses, especially in the event of a significant adverse movement in the value of any foreign currency in which we conduct business against any of our functional currencies, including the U.S. dollar.
Our primary net foreign currency exposures as of February 2, 2025, included the South Korean won, the Japanese yen, the New Taiwan dollar, the Chinese yuan, the Singapore dollar, the British pound sterling, and the euro. As of that date, a 10% adverse movement in the value of currencies different from the functional currencies of our subsidiaries would have resulted in a net unrealized pre-tax loss of $62.7 million, which represents an increase of $1.4 million from our exposure at October 31, 2024. Our most significant exposures at February 2, 2025, were exposures of the South Korean won, the Chinese yuan, and the New Taiwan dollar to the U.S. dollar, which were, respectively, $19.6 million, $7.3 million, and $33.0 million at that date. We do not believe that a 10% change in the exchange rates of non-US dollar currencies, other than the aforementioned currencies and the Japanese yen, would have had a material effect on our February 2, 2025, condensed consolidated financial statements.
Interest Rate Risk
A 10% adverse or favorable movement in the interest rates on our variable rate borrowings would not have had a material effect on the Company’s February 2, 2025, condensed consolidated financial statements
, as there were no variable rate borrowings outstanding as of the balance sheet date
.
Item 4.
CONTROLS AND PROCEDURES
Evaluation of Disclosure Controls and Procedures
We have established, and currently maintain, disclosure controls and procedures, as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act, designed to provide reasonable assurance that information required to be disclosed in reports filed under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms, and that such information is accumulated and communicated to management, including our chief executive officer and chief financial officer, as appropriate, to allow for timely decisions regarding required disclosure. In designing and evaluating disclosure controls and procedures, management recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Our management, under the supervision and with the participation of our chief executive officer and chief financial officer, evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, our chief executive officer and chief financial officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of the end of the period covered by this report.
Changes in Internal Control over Financial Reporting
There were no changes in the Company’s internal control over financial reporting during the first fiscal quarter ended February 2, 2025, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
30
Table of Contents
PART II. OTHER INFORMATION
Item 1.
LEGAL PROCEEDINGS
Please refer to Note 12 within Part I, Item 1 of this report for information on legal proceedings involving the Company.
Item 1A.
RISK FACTORS
There have been no material changes to our risk factors as set forth in “Item 1A. Risk Factors” in our 2024 Form 10-K.
Item 2.
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
Issuer Purchases of Equity Securities
In September 2020, the Company’s Board of Directors authorized the repurchase of up to $100 million of its common stock, pursuant to a repurchase plan under Rule 10b-18 of the Exchange Act. The repurchase authorization by the Board of Directors has no expiration date, does not obligate us to acquire any common stock, and is subject to market conditions. From September 2020 through October 2022, the Company repurchased 5.8 million shares at a cost of $68.3 million. In August 2024, the Board of Directors authorized an increase to the Company’s existing share repurchase program from the remaining $31.7 million up to $100 million. During the three-month period ended February 2, 2025, the Company repurchased 195,079 shares at a cost $4.6 million pursuant to Rule 10b-18 of the Exchange Act. All shares repurchased under the program have been retired. As of February 2, 2025, $95.4 million remained available under this authorization for the repurchase of additional shares.
The following table provides information relating to the Company’s repurchase of common stock during the first quarter of fiscal year 2025. This table excludes shares repurchased to settle employee tax withholding related to the vesting of stock awards.
Total
Number of
Shares
Purchased
Average
Price
Paid
Per share
Total Number
of Shares
Purchased as
Part of Publicly
Announced
Program
Dollar Value of
Shares That May
Yet Be Purchased
(in millions)
November 1, 2024 – December 1, 2024
-
-
-
$
100
December 2, 2024 – December 29, 2024
-
-
-
$
100
December 30, 2024 – February 2, 2025
195,079
$
23.42
195,079
$
95.4
Total
195,079
195,079
Certain lease arrangements include limitations on the amounts of dividends we may pay. Please refer to Note 7 of the condensed consolidated financial statements for information on these limitations.
Item 3.
DEFAULTS UPON SENIOR SECURITIES
None.
Item 4.
MINE SAFETY DISCLOSURES
Not applicable
31
Table of Contents
Item 5.
OTHER INFORMATION
Rule 10b5-1 Trading Arrangements
Our directors and officers (as defined in Rule 16a-1 under the Exchange Act) may from time to time enter into plans or other arrangements for the purchase or sale of our shares that are intended to satisfy the affirmative defense conditions of Rule 10b5–1(c) or may represent a non-Rule 10b5-1 trading arrangement under the Exchange Act.
During the quarter ended February 2, 2025, the following directors and officers as defined in Rule 16a-1(f) of the Exchange Act, adopted a “Rule 10b5-1 trading arrangement” as defined in Item 408 of Regulation S-K:
On
December 19, 2024
,
Mitchell G. Tyson
, a
member of our Board of Directors
,
adopted
a Rule
10b5-1
trading arrangement (the “Tyson Plan”) providing for the sale of an aggregate of up to
30,000
shares of our common stock granted to Mr. Tyson under our compensation program. The first date any shares are permitted to be sold under the Tyson Plan is
April 1, 2025
and the last day shares are permitted to be sold under the Tyson Plan is
November 28, 2025
.
On
December 23, 2024
,
Christopher J. Progler
, Ph.D., our
Executive Vice President and Chief Technology Officer
,
adopted
a Rule
10b5-1
trading arrangement (the “Progler Plan”) providing for the sale of an aggregate of up to
40,000
shares of our common stock granted to Dr. Progler under our compensation program. The first date any shares are permitted to be sold under the Progler Plan is
March 24, 2025
and the last day shares are permitted to be sold under the Progler Plan is
December 31, 2025
.
The Tyson Plan and the Progler Plan are intended to satisfy the affirmative defense in Rule 10b5-1(c).
No other such plans or arrangements were
adopted
or
terminated
, including by modification, by any director or officer (as defined in Rule 16a-1 under the Exchange Act) during the quarter ended February 2, 2025.
32
Table of Contents
Item 6.
EXHIBITS
Incorporated by Reference
Exhibit
Number
Description
Form
Exhibit
Filing Date
Filed or Furnished Herewith
31.1
Certification of Chief Executive Officer pursuant to Rule 13a-14(a)/15d-14(a)
of the Exchange Act, as adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002.
X
31.2
Certification of Chief Financial Officer pursuant to Rule 13a-14(a)/15d-14(a)
of the Exchange Act, as adopted pursuant to Section 302 of
the Sarbanes-Oxley Act of 2002.
X
32.1
Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
X
32.2
Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
X
101.INS
Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
X
101.SCH
Inline XBRL Taxonomy Extension Schema Document
X
101.CAL
Inline XBRL Taxonomy Extension Calculation Linkbase Document
X
101.DEF
Inline XBRL Taxonomy Extension Definition Linkbase Document
X
101.LAB
Inline XBRL Taxonomy Extension Label Linkbase Document
X
101.PRE
Inline XBRL Taxonomy Extension Presentation Linkbase Document
X
104
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
X
33
Table of Contents
SIGNATURES
Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Photronics, Inc.
(Registrant)
By:
/s/ ERIC RIVERA
ERIC RIVERA
Executive Vice President,
Chief Financial Officer
(Principal Financial Officer
/Principal Accounting Officer)
Date:
March 13, 2025
34